96-week results of a dual therapy with darunavir/ritonavir plus rilpivirine once a day vs triple therapy in patients with suppressed viraemia: virological success and non-HIV related morbidity evaluation

Autor: Di Cristo V, Adorni F, Maserati R, Annovazzi Lodi M, Bruno G, Maggi P, Volpe A, Vitiello P, Abeli C, Bonora S, Ferrara M, Cossu MV, Oreni ML, Colella E, Rusconi S.

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od______3977::b37e42578ff909fc1bcb7e9a79bb6a11
http://hdl.handle.net/11591/427810

Clinical and genetic determinants of nevirapine plasma trough concentration.

Autor: Giacomelli A; Infectious Diseases Unit, Department of Biomedical and Clinical Sciences 'Luigi Sacco,' University of Milan, Milan, Italy., Rusconi S; Infectious Diseases Unit, Department of Biomedical and Clinical Sciences 'Luigi Sacco,' University of Milan, Milan, Italy., Falvella FS; Clinical Pharmacology Unit, ASST Fatebenefratelli Sacco, Milan, Italy., Oreni ML; Infectious Diseases Unit, Department of Biomedical and Clinical Sciences 'Luigi Sacco,' University of Milan, Milan, Italy., Cattaneo D; Clinical Pharmacology Unit, ASST Fatebenefratelli Sacco, Milan, Italy., Cozzi V; Clinical Pharmacology Unit, ASST Fatebenefratelli Sacco, Milan, Italy., Renisi G; Infectious Diseases Unit, Department of Biomedical and Clinical Sciences 'Luigi Sacco,' University of Milan, Milan, Italy., Monge E; Infectious Diseases Unit, Department of Biomedical and Clinical Sciences 'Luigi Sacco,' University of Milan, Milan, Italy., Cheli S; Clinical Pharmacology Unit, ASST Fatebenefratelli Sacco, Milan, Italy., Clementi E; Clinical Pharmacology Unit, ASST Fatebenefratelli Sacco, Milan, Italy.; Eugenio Medea Scientific Institute, Bosisio Parini, Italy., Riva A; Infectious Diseases Unit, Department of Biomedical and Clinical Sciences 'Luigi Sacco,' University of Milan, Milan, Italy., Galli M; Infectious Diseases Unit, Department of Biomedical and Clinical Sciences 'Luigi Sacco,' University of Milan, Milan, Italy., Ridolfo AL; Infectious Diseases Unit, Department of Biomedical and Clinical Sciences 'Luigi Sacco,' University of Milan, Milan, Italy.

Publikováno v: SAGE open medicine [SAGE Open Med] 2018 Jun 05; Vol. 6, pp. 2050312118780861. Date of Electronic Publication: 2018 Jun 05 (Print Publication: 2018).

Treatment outcome in HIV+ patients receiving 3- or 4-drug regimens during PHI.

Autor: Bottani GM; Infectious Diseases Unit, DIBIC Luigi Sacco, Milan, Italy., Oreni ML; Infectious Diseases Unit, DIBIC Luigi Sacco, Milan, Italy., Orofino G; Infectious Diseases Unit A, Amedeo di Savoia Hospital, Turin, Italy., Tau P; Infectious Diseases Unit, DIBIC Luigi Sacco, Milan, Italy., Di Nardo Stuppino S; Infectious Diseases Unit, DIBIC Luigi Sacco, Milan, Italy., Colella E; Infectious Diseases Unit, DIBIC Luigi Sacco, Milan, Italy., Carosella S; Infectious Diseases Unit A, Amedeo di Savoia Hospital, Turin, Italy., Guastavigna M; Infectious Diseases Unit A, Amedeo di Savoia Hospital, Turin, Italy., Ghisetti V; Microbiology and Virology Laboratory, Amedeo di Savoia Hospital, Turin, Italy., Micheli V; Clinical Microbiology, Virology and Bioemergency, Luigi Sacco Hospital, Milan, Italy., Galli M; Infectious Diseases Unit, DIBIC Luigi Sacco, Milan, Italy., Rusconi S; Infectious Diseases Unit, DIBIC Luigi Sacco, Milan, Italy.

Publikováno v: Journal of the International AIDS Society [J Int AIDS Soc] 2014 Nov 02; Vol. 17 (4 Suppl 3), pp. 19778. Date of Electronic Publication: 2014 Nov 02 (Print Publication: 2014).